Volume 26, Issue 4 (Iranian South Medical Journal 2024)
Iran South Med J 2024, 26(4): 212-223 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sepahi R, Jorjani E, Afshari A, Sabouri H, Yaghobi R. The Effect of BK Virus and Host Cell MicroRNAs in Kidney Transplant. Iran South Med J 2024; 26 (4) :212-223
URL: http://ismj.bpums.ac.ir/article-1-1857-en.html
URL: http://ismj.bpums.ac.ir/article-1-1857-en.html
1- Department of Biology, School of Science, Gonbad Kavous University, Gonbad-E Kavous, Iran
2- Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ,afsafshari@yahoo.com
3- Department of Plant Production, School of Agriculture Science and Natural Resources, Gonbad Kavous University, Gonbad-E Kavous, Iran
4- Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2- Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran ,
3- Department of Plant Production, School of Agriculture Science and Natural Resources, Gonbad Kavous University, Gonbad-E Kavous, Iran
4- Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract: (899 Views)
Background: Polyomavirus BK is one of the life-threatening infections in kidney transplant recipients. The activation of this virus can eventually lead to the loss of the graft. There are very few studies on the expression level of BK virus microRNAs. Therefore, in this study, we investigated the function of BK virus microRNAs and their effect on host cell microRNAs’ expression level. BK virus encodes two microRNAs, namely miR-B1-3p and miR-B1-5p. Therefore, it is crucial to study these microRNAs as markers of viral infection and their regulation. So far, there is no approved drug or vaccine to treat BK virus infection. Consequently, understanding the relationship between BK virus and host cell microRNAs is integral to the control of infection in kidney transplant patients.
Materials and Methods: In this study, ten tissue samples from kidney transplant recipients with symptoms of BK virus nephropathy, ten urine samples from kidney transplant patients without active BK virus infection, and 20 healthy individuals were included. The expression level of the studied microRNAs was measured in all the samples using SYBR Green Real-time PCR.
Results: The results showed that the expression level of the studied microRNAs, including miR-B1-3p, miR-B1-5p, miR-155, miR-520, miR-10b, miR-30a in the tissue samples of kidney transplant patients with BK virus nephropathy symptoms were significantly increased compared to kidney transplant patients without active BK virus infection.
Conclusion: The assessment of some microRNAs, such as miR-520, miR-30a, and miR-B1-3p/5p, may assist in the prediction and prevention of BKPyV activation in KTRs, particularly in urine samples.
Materials and Methods: In this study, ten tissue samples from kidney transplant recipients with symptoms of BK virus nephropathy, ten urine samples from kidney transplant patients without active BK virus infection, and 20 healthy individuals were included. The expression level of the studied microRNAs was measured in all the samples using SYBR Green Real-time PCR.
Results: The results showed that the expression level of the studied microRNAs, including miR-B1-3p, miR-B1-5p, miR-155, miR-520, miR-10b, miR-30a in the tissue samples of kidney transplant patients with BK virus nephropathy symptoms were significantly increased compared to kidney transplant patients without active BK virus infection.
Conclusion: The assessment of some microRNAs, such as miR-520, miR-30a, and miR-B1-3p/5p, may assist in the prediction and prevention of BKPyV activation in KTRs, particularly in urine samples.
Type of Study: Original |
Subject:
Virology
Received: 2024/01/2 | Accepted: 2024/02/5 | Published: 2024/03/3
Received: 2024/01/2 | Accepted: 2024/02/5 | Published: 2024/03/3
References
1. Pattar SK, Greenway SC. Circulating nucleic acids as biomarkers for allograft injury after solid organ transplantation: current state-of-theart. Transpl Res Risk Manag 2019: 17-27. [DOI]
2. Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant 2015; 30(2): 209-17. [DOI]
3. Afshari A, Yaghobi R, Rezaei G. Interregulatory role of microRNAs in interaction between viruses and stem cells. World J Stem Cells 2021; 13(8): 985-1004. [DOI]
4. Soltaninejad E, Nicknam MH, Nafar M, et al. Altered expression of microRNAs following chronic allograft dysfunction with interstitial fibrosis and tubular atrophy. Iran J Allergy Asthma Immunol 2015; 14(6): 615-23. [PubMed]
5. Golsha R, Gooran Orimi A, Khodabakhshi B, et al. Prevalence of infectious diseases in patients with end stage renal disease in Gorgan City in Iran. Tehran Univ Med J 2020; 78(4): 233-8. (Persian) [Article]
6. Li JY, McNicholas K, Yong TY, et al. BK virus encoded microRNAs are present in blood of renal transplant recipients with BK viral nephropathy. Am J Transplant 2014; 14(5): 1183-90. [DOI]
7. Haddad G, Kölling M, Lorenzen JM. The hypoxic kidney: pathogenesis and noncoding RNA-based therapeutic strategies. Swiss Med Wkly 2019; 149: w14703. [DOI]
8. Gámez-Valero A, Lozano-Ramos SI, Bancu I, et al. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol 2015; 6: 6. [DOI]
9. O'Brien J, Hayder H, Zayed Y, et al. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018; 9: 402. [DOI]
10. Zeng G, Wang Z, Huang Y, et al. Cellular and viral miRNA expression in polyomavirus BK infection. Transpl Infect Dis 2019; 21(5): e13159. [DOI]
11. Yaghobi R, Afshari A, Roozbeh J. Host and viral RNA dysregulation during BK polyomavirus infection in kidney transplant recipients. Wiley Interdiscip Rev RNA 2023; 14(4): e1769. [DOI]
12. Kariminik A, Yaghobi R, Dabiri S. Innate immunity and BK virus: prospective strategies. Viral Immunol 2016; 29(2): 74-82. [DOI]
13. Foroudi MR, Yaghobi R, Afshari A, et al. The effect of the BK polyomavirus large T antigen on the function and maturity of the CD4+ T cell subsets in kidney transplant recipients. Transpl Immunol 2023; 80: 101884. [DOI]
14. Foroudi MR, Yaghobi R, Afshari A, et al. The effect of BK polyomavirus large T antigen on CD4 and CD8 T cells in kidney transplant recipients. Transpl Immunol 2022; 74: 101655. [DOI]
15. Sun IO, Lerman LO. Urinary microRNA in kidney disease: Utility and roles. Am J Physiol Renal Physiol 2019; 316(5): F785-F793. [DOI]
16. Noshadi N, Yaghoubi R, Afshari A, et al. Impaired CD4+ Cytotoxic T Lymphocyte Activity in Polyomavirus BK Infected Kidney Transplant Recipients. Iran J Allergy Asthma Immunol 2023; 22(4): 379-389. [DOI]
17. Zou W, Imperiale MJ. Biology of polyomavirus miRNA. Front Microbiol 2021; 12: 662892. [DOI]
18. Bauman Y, Nachmani D, Vitenshtein A, et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 2011; 9(2): 93-102. [DOI]
19. Huang Y, Zeng G, Randhawa PS. Detection of BKV encoded mature MicroRNAs in kidney transplant patients: Clinical and biologic insights. J Clin Virol 2019; 119: 6-10. [DOI]
20. Wilflingseder J, Regele H, Perco P, et al. miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation 2013; 95(6): 835-41. [DOI]
21. Li J, Yue S, Fang J, et al. MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease. Mol Ther Nucleic Acids 2022; 28: 488-99. [DOI]
22. Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol 2018; 141(4): 1202-7. [DOI]
23. Song K, Jiang Y, Zhao Y, et al. Members of the miR‑30 family inhibit the epithelial‑to‑mesenchymal transition of non‑small‑cell lung cancer cells by suppressing XB130 expression levels. Oncol Lett 2020; 20(4): 68. [DOI]
24. Mahmudpour M, Nabipour I, Esmailie AH, at al. A Case of Systemic Lupus Erythematosus with Renal Failure Following the Administration of Sinopharm COVID -19 Vaccine. Iran South Med J 2022; 25(3): 277- 284. (Persian) [DOI]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
